Viral mimic systems and other tech platforms could enable local testing of vaccine candidates and antiviral therapies. This ...

A new vaccine design uses folded DNA to steer the immune system toward producing the rare immune cells needed to make ...

VLP technology shows remarkable versatility. Dozens of vaccine candidates are in development for infectious diseases, inflammatory conditions and even cancer. These particles are made up of viral ...

Vaccines that resemble viruses generally produce a stronger immune response, while mRNA versions are much quicker and cheaper to make. Now we are getting the best of both worlds, in the form of mRNA ...

Earlier this month, the Trump administration said it was terminating $500 million in mRNA vaccine research and shifting its focus to other approaches, including a previously announced “whole-virus” ...